| 000 | 01870nam a2200457Ii 4500 | ||
|---|---|---|---|
| 001 | DIGUNSAL0078 | ||
| 003 | NyNyDIG | ||
| 006 | m o d | ||
| 008 | 190305s2015 sp ob 000 0 spa d | ||
| 007 | cr ||||||||||| | ||
| 035 | _a(OCoLC)1089530532 | ||
| 040 |
_aDGITA _beng _erda _epn _cDGITA |
||
| 020 |
_a9788490125328 _q(eBook ; _qpdf) |
||
| 020 |
_a8490125325 _q(eBook ; _qpdf) |
||
| 050 | 1 | 4 | _aRC606.7 ebook |
| 082 | 0 | 4 | _a616.9792061 |
| 100 | 1 |
_aLópez Aspiroz, Elena, _eauthor. _9122634 |
|
| 245 | 1 | 0 |
_aOptimización de la terapia con lopinavir/ritonavir en pacientes infectados por el VIH : _baplicación de criterios farmacocinéticos y farmacogenéticos / _cElena López Aspiroz. |
| 264 | 1 |
_aSalamanca (España) : _bEdiciones Universidad de Salamanca, _c[2015] |
|
| 300 | _a1 online resource. | ||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_acomputer _bc _2rdamedia |
||
| 338 |
_aonline resource _bcr _2rdacarrier |
||
| 490 | 1 |
_aColección Vítor ; _v369 |
|
| 500 | _aOriginally presented as the author's thesis (doctoral)--Universidad de Salamanca, 2015. | ||
| 504 | _aIncludes bibliographical references. | ||
| 588 | 0 | _aOnline resource; title from PDF title page (Digitalia, viewed March 8, 2019) | |
| 650 | 0 |
_aHIV infections _xTreatment. |
|
| 650 | 0 |
_aHIV-positive persons _xTreatment. _9122636 |
|
| 650 | 0 |
_aProtease inhibitors _xTherapeutic use. _9122637 |
|
| 650 | 2 |
_aLopinavir. _9122638 |
|
| 650 | 2 |
_aRitonavir. _9122639 |
|
| 655 | 0 | _aElectronic books. | |
| 791 | 2 |
_aDigitalia (Firm), _edistributor. |
|
| 793 | 0 |
_gDigitalia eBook Collection: _aEdiciones Universidad de Salamanca |
|
| 830 | 0 |
_aColección Vítor ; _v369. _982392 |
|
| 856 | 4 | 0 |
_3Digitalia Hispánica _uhttps://login.zproxy.cun.edu.co/login?url=https://www.digitaliapublishing.com/a/42069/ |
| 910 | _aPremium collection: 2019 | ||
| 942 | _cE-BOOK | ||
| 942 | _2ddc | ||
| 999 |
_c43260 _d43260 |
||